Tetrahydronaphthalene and tetrahydroquinoline compounds, their p

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514570, 546153, 546155, 562492, C07D215233, C07C 3914, C07C 3917, A61K 31045

Patent

active

061332860

ABSTRACT:
This invention relates to novel benzopyran and other benzo-fused leukotriene B.sub.4 (LTB.sub.4) antagonists and the pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing such compounds or a pharmaceutically acceptable salt thereof, and to methods of using such compounds as LTB.sub.4 antagonists. The compounds and the pharmaceutically acceptable salts of this invention inhibit the action of LTB.sub.4 and are therefore useful in the treatment of LTB.sub.4 induced illnesses such as inflammatory disorders including rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, psoriasis and other skin disorders such as eczema, erythema, pruritus and acne, stroke and other forms of reperfusion injury, graft rejection, autoimmune diseases, asthma, and other conditions where marked neutrophil infiltration occurs.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tetrahydronaphthalene and tetrahydroquinoline compounds, their p does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetrahydronaphthalene and tetrahydroquinoline compounds, their p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydronaphthalene and tetrahydroquinoline compounds, their p will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-469333

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.